Cargando…
Health following recovery from immune thrombotic thrombocytopenic purpura: the patient’s perspective
The impact of residual symptoms following recovery from immune-mediated thrombotic thrombocytopenic purpura (iTTP) on activities of daily living during remission is not routinely discussed or evaluated by hematologists. This study used qualitative methodology to understand 3 issues from the patient’...
Autores principales: | Kelley, Rachel A., Cheney, Marshall K., Martin, Clare M., Cataland, Spero, Quick, Lauren B., Keller, San, Vesely, Sara K., Llaneza, Amanda J., Khawandanah, Mohamad O., Journeycake, Janna M., Panepinto, Julie A., Terrell, Deirdra R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164827/ https://www.ncbi.nlm.nih.gov/pubmed/36287218 http://dx.doi.org/10.1182/bloodadvances.2022008342 |
Ejemplares similares
-
Novel therapies in thrombotic thrombocytopenic purpura
por: Masias, Camila, et al.
Publicado: (2017) -
Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management
por: Sukumar, Senthil, et al.
Publicado: (2021) -
Shared decision making, thrombotic thrombocytopenic purpura, and caplacizumab
por: Sukumar, Senthil, et al.
Publicado: (2020) -
Clinical relapse of immune‐mediated thrombotic thrombocytopenic purpura following COVID‐19 vaccination
por: Deucher, William, et al.
Publicado: (2022) -
SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura
por: Shah, Hridaya, et al.
Publicado: (2022)